Press release

Pharma Company Boosts Sales and Profitability by Capitalizing on Emerging Opportunities Identified Using Quantzig’s Customer Segmentation Analytics Solutions

Sponsored by Businesswire

Customer segmentation has been an age-old issue for businesses globally. Though new customer segmentation models have helped serve the purpose, it tends to miss certain aspects that make it unreliable in the long run. Quantzig has an extensive team that comprises data scientists and advanced customer analytics experts who focus on data analysis and implement analytics approaches to tackle challenges like these. The cross-functional teams work closely with businesses to help them deal with large real-world databases and identify various risk factors and analyze factors that impact outcomes. Quantzig also has the expertise in offering a wide range of customer segmentation analytics solutions that can help tackle a plethora of challenges faced by companies in the retail, F&B, CPG, and BFSI sectors.

This press release features multimedia. View the full release here:

Global Pharmaceutical Industry Challenges (Graphic: Business Wire)

Global Pharmaceutical Industry Challenges (Graphic: Business Wire)

Quantzig’s approach to customer segmentation combines the application of dynamic micro-segmentation and predictive modeling techniques to accurately forecast customer value based on their purchase history, demographics, and other behavioral traits. Request a FREE proposal to know more.

While customer segmentation has been crucial in driving business value across industries, the implementation of the right strategy has always been a challenge for e-tailers. As such, customer segmentation strategy creation has become crucial to gain a leading edge. However, with the evolution of technology and the growth of insightful datasets, customer segmentation is now a much easier task for organizations that possess the analytics capabilities and skillsets.

Rapidly changing healthcare and pharma landscape pose a major challenge for pharma customer segmentation

The pharmaceutical industry, as we know it today, is extremely competitive and dynamic. This has necessitated companies in the pharmaceutical industry to shift their focus towards consumerism.

To stay ahead of the curve, pharma companies need to effectively target promotional activities toward consumers who are most likely to respond to their marketing efforts. As such, pharma companies need to get away with traditional marketing approaches to reach consumers in a rapidly changing healthcare environment.

Quantzig is at the forefront of enabling business innovation to facilitate better outcomes and business reach. Contact us to learn more about our customer analytics capabilities.

Engagement Overview

Having expanded its market footprint, the client, a leading German pharmaceutical company, wanted to classify customers in the new market based on their needs and specific behavioral and demographic patterns.

Quantzig’s cross-functional team of 550+ seasoned customer segmentation analytics experts and data science professionals adopted a comprehensive three-step approach that focused on the development of a holistic customer segmentation analytics framework. The analytics experts at Quantzig also leveraged robust statistical tools and response modeling techniques to glean actionable insights into various customer segments. Consequently, the client witnessed a significant improvement in the ROI generated from their personalized campaigns, achieving an overall increase of 23% in sales and profitability. The complete success story on customer segmentation analytics is now available.

Are you looking for more information? Book a FREE Demo to learn more about our proprietary customer analytics platform capabilities.

Keep abreast of the latest trends in customer segmentation by following the latest insights from our analytics experts > Follow us on LinkedIn and Twitter.

About Quantzig

Quantzig is a global analytics and advisory firm with offices in the US, UK, Canada, China, and India. For more than 15 years, we have assisted our clients across the globe with end-to-end data modeling capabilities to leverage analytics for prudent decision making. Today, our firm consists of 120+ clients, including 45 Fortune 500 companies. For more information on our engagement policies and pricing plans, visit: